發改委產業發展司組織召開工業機器人重點企業座談會
據國家發展改革委員會消息,為順應新一輪產業變革趨勢,精準研判工業機器人產業發展形勢,推動我國相關產業健康穩步發展,國家發展改革委員會產業發展司近日在京組織召開工業機器人重點企業座談會,中國機器人產業聯盟、埃夫特、埃斯頓、固高科技、瀋陽新鬆、美的集團、廣東長盈等相關單位和企業代表參加。會上,各企業介紹了2019年工業機器人相關產品生產銷售情況以及對下一階段市場走勢的判斷,並積極展開交流探討,提出了引導我國工業機器人產業高質量發展的意見建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.